ADVANZ PHARMA’s Post

The shift is on. As an increasing percentage of pharma budgets flow to companies not affiliated with holding companies, there’s been a mass reorganization of value within this year's Agency 100. Read more in our overview today. https://brnw.ch/21wL42l #MMMAgency100 #pharmamarketing #healthcareagencies #brandagency #advertisingagency #marcomms

The shift is on. As an increasing percentage of pharma budgets flow to companies not affiliated with holding companies, there’s been a mass reorganization of value within this year's Agency 100. Read more in our overview today. https://brnw.ch/21wKOAP #MMMAgency100 #pharmamarketing #healthcareagencies #brandagency #advertisingagency #marcomms

Our latest edition of The Healthcare Check-Up, analyzing activity in the healthcare services sector for Q3 2023, is now available. Market conditions suggest potential growth in healthcare despite recent declines in financing and M&A. Key trends include a focus on facility-based hospitals, Vistria Group's acquisition, IPOs from Ardent Health and Guardian Pharmacy Services, and an FTC lawsuit against major PBMs impacting the prescription drug market. Read the full Q3 newsletter here: https://lnkd.in/gv2J6Gzj #healthcareservices #IPO #PBM #prescriptiondrugmarket

The shift is on. As an increasing percentage of pharma budgets flow to companies not affiliated with holding companies, there’s been a mass reorganization of value within this year's Agency 100. Read more in our overview today. https://lnkd.in/eMhCJaWF #MMMAgency100 #pharmamarketing #healthcareagencies #brandagency #advertisingagency #marcomms

“Fitch Ratings has moderated its expectations for three subsectors (healthcare supply chain, diagnostics, and contract research organizations) in the U.S. Healthcare & Pharma industry while raising its expectations for generic pharma. The healthcare supply chain faces growing risks from customer concentration due to pressure on retail pharmacies and scrutiny of pharmacy benefit managers. Moreover, the Inflation Reduction Act (IRA) is prompting cost reductions in pharmaceutical R&D, potentially lowering revenues for contract research organizations and delaying the rebound of diagnostics firms. The next milestone will be the release of negotiated drug prices in 3Q24.” Subscribers to Fitch Ratings PRO can read the full report via the link below.

The shift is on. As an increasing percentage of pharma budgets flow to companies not affiliated with holding companies, there’s been a mass reorganization of value within this year's Agency 100. Read more in our overview today. https://lnkd.in/eMhCJaWF #MMMAgency100 #pharmamarketing #healthcareagencies #brandagency #advertisingagency #marcomms

🌟 Navigating the Evolving Pharmacy Landscape: A Call to Action for Healthcare Professionals 🌟 The pharmacy sector is experiencing significant transformations, with recent developments such as Amazon's entry into the generic medications market and the introduction of advanced weight-loss drugs by Eli Lilly and Novo Nordisk. These changes underscore the need for healthcare organizations to adapt swiftly to maintain optimal patient care and operational efficiency. At Wellyfe, we are dedicated to guiding healthcare providers through these dynamic times by offering: 1️⃣ Direct Pharmacy Care Models: We assist in reducing prescription health plan expenditures and establishing new revenue streams, ensuring financial sustainability amid industry shifts. 2️⃣ 340B Program Optimization: Our expertise helps organizations maximize savings and compliance, crucial as the pharmaceutical landscape evolves. 3️⃣ Customized PBM Strategies: We help organizations break free from traditional PBM models by implementing transparent, in-house solutions that prioritize cost control, improve prescription access, and align benefits with organizational goals. By staying ahead of industry changes, Wellyfe empowers healthcare organizations to deliver exceptional patient care while achieving operational excellence. 💡 Let’s connect! #PharmacyInnovation #HealthcareTransformation #340BOptimization #PBMReform #Wellyfe #PatientCare

The latest specialty distribution industry trends and metrics are now available from the HDA - Healthcare Distribution Alliance Research Foundation. Reflecting FY23, download the free report for insights into how specialty distributors efficiently and reliably deliver increasingly complex products. https://bit.ly/3C73ooy

The latest specialty distribution industry trends and metrics are now available from the HDA Healthcare Distribution Alliance Research Foundation. Reflecting FY23, download the free report for insights into how specialty distributors efficiently and reliably deliver increasingly complex products. https://bit.ly/3C73ooy

In the dynamic world of pharmaceutical sales, building relationships, understanding customer needs, and delivering innovative solutions remain at the heart of what we do. Success in this industry isn’t just about selling; it’s about providing value to healthcare professionals and ensuring better outcomes for patients. As we navigate evolving challenges—shifting regulations, competitive landscapes, and digital transformation—let’s remember the power of collaboration, adaptability, and continuous learning. Here’s to raising the bar, exceeding expectations, and making a difference in healthcare! #PharmaSales #HealthcareInnovation #PatientFirst #SalesExcellence STADA Group STADA Emerging Markets